USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	066182/0174			Pages:	12
		Recorded:	01/19/2024
Attorney Dkt #:	034550.00068
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 26

1

Patent #:	11524064	Issue Dt:	12/13/2022	Application #:	16927086	Filing Dt:	07/13/2020
Publication #:	US20210093707	Pub Dt:	04/01/2021
Title:	ZIKA VIRUS PURIFICATION

2

Patent #:	11572392	Issue Dt:	02/07/2023	Application #:	16990023	Filing Dt:	08/11/2020
Publication #:	US20210054032	Pub Dt:	02/25/2021
Title:	MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

3

Patent #:	11357844	Issue Dt:	06/14/2022	Application #:	17061891	Filing Dt:	10/02/2020
Publication #:	US20210121554	Pub Dt:	04/29/2021
Title:	ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF

4

Patent #:	NONE	Issue Dt:		Application #:	17260054	Filing Dt:	01/13/2021
Publication #:	US20210275662	Pub Dt:	09/09/2021
Title:	METHOD FOR RESCUING AND PRODUCING A VIRUS IN AVIAN CELLS

5

Patent #:	NONE	Issue Dt:		Application #:	17393888	Filing Dt:	08/04/2021
Publication #:	US20220125917	Pub Dt:	04/28/2022
Title:	METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES

6

Patent #:	11478540	Issue Dt:	10/25/2022	Application #:	17406765	Filing Dt:	08/19/2021
Publication #:	US20210393761	Pub Dt:	12/23/2021
Title:	ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF

7

Patent #:	11684669	Issue Dt:	06/27/2023	Application #:	17471904	Filing Dt:	09/10/2021
Publication #:	US20230038284	Pub Dt:	02/09/2023
Title:	CpG-ADJUVANTED SARS-CoV-2 VIRUS VACCINE

8

Patent #:	NONE	Issue Dt:		Application #:	17517477	Filing Dt:	11/02/2021
Publication #:	US20220185851	Pub Dt:	06/16/2022
Title:	MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

9

Patent #:	12005111	Issue Dt:	06/11/2024	Application #:	17548721	Filing Dt:	12/13/2021
Publication #:	US20220273786	Pub Dt:	09/01/2022
Title:	ZIKA VIRUS VACCINE

10

Patent #:	NONE	Issue Dt:		Application #:	17606811	Filing Dt:	10/27/2021
Publication #:	US20220185847	Pub Dt:	06/16/2022
Title:	A SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION

11

Patent #:	NONE	Issue Dt:		Application #:	17632943	Filing Dt:	02/04/2022
Publication #:	US20220288185	Pub Dt:	09/15/2022
Title:	CHIKUNGUNYA VACCINE FORMULATIONS

12

Patent #:	NONE	Issue Dt:		Application #:	17632946	Filing Dt:	02/04/2022
Publication #:	US20220313810	Pub Dt:	10/06/2022
Title:	SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE

13

Patent #:	NONE	Issue Dt:		Application #:	17688960	Filing Dt:	03/08/2022
Publication #:	US20220298493	Pub Dt:	09/22/2022
Title:	INACTIVATION PROCESS FOR VIRUSES

14

Patent #:	NONE	Issue Dt:		Application #:	17811059	Filing Dt:	07/06/2022
Publication #:	US20230056142	Pub Dt:	02/23/2023
Title:	VIRUS PURIFICATION

15

Patent #:	NONE	Issue Dt:		Application #:	17917010	Filing Dt:	10/05/2022
Publication #:	US20230398210	Pub Dt:	12/14/2023
Title:	IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE

16

Patent #:	NONE	Issue Dt:		Application #:	17917016	Filing Dt:	10/05/2022
Publication #:	US20240026412	Pub Dt:	01/25/2024
Title:	IMPROVED METHODS OF PRODUCING A LIPIDATED PROTEIN

17

Patent #:	NONE	Issue Dt:		Application #:	17917624	Filing Dt:
Publication #:	US20230173051	Pub Dt:	06/08/2023
Title:	COMPOSITIONS COMPRISING THREE OSPA FUSION PROTEINS FOR MEDICAL USE

18

Patent #:	NONE	Issue Dt:		Application #:	17930742	Filing Dt:	09/09/2022
Publication #:	US20230173052	Pub Dt:	06/08/2023
Title:	ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF

19

Patent #:	NONE	Issue Dt:		Application #:	17932226	Filing Dt:	09/14/2022
Publication #:	US20230295245	Pub Dt:	09/21/2023
Title:	MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

20

Patent #:	NONE	Issue Dt:	06/18/2024	Application #:	17935490	Filing Dt:	09/26/2022
Publication #:	US20230293661	Pub Dt:	09/21/2023
Title:	METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

21

Patent #:	NONE	Issue Dt:		Application #:	18027657	Filing Dt:	03/22/2023
Publication #:	US20230372464	Pub Dt:	11/23/2023
Title:	CHOLERA VACCINE FORMULATION

22

Patent #:	NONE	Issue Dt:		Application #:	18150971	Filing Dt:	01/06/2023
Publication #:	US20230322869	Pub Dt:	10/12/2023
Title:	MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

23

Patent #:	11951163	Issue Dt:	04/09/2024	Application #:	18178638	Filing Dt:	03/06/2023
Publication #:	US20230226165	Pub Dt:	07/20/2023
Title:	ZIKA VIRUS VACCINE

24

Patent #:	NONE	Issue Dt:		Application #:	18285416	Filing Dt:	10/03/2023
Publication #:	US20240181034	Pub Dt:	06/06/2024
Title:	HUMAN METAPNEUMO VIRUS VACCINE

25

Patent #:	NONE	Issue Dt:		Application #:	18334497	Filing Dt:	06/14/2023
Publication #:	US20240108712	Pub Dt:	04/04/2024
Title:	ZIKA VIRUS VACCINE

26

Patent #:	NONE	Issue Dt:		Application #:	18493004	Filing Dt:	10/24/2023
Publication #:	US20240067681	Pub Dt:	02/29/2024
Title:	SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION

Assignors

1

Exec Dt:

01/19/2024

2

VALNEVA AUSTRIA GMBH

Exec Dt:

01/19/2024

3

VALNEVA USA, INC.

Exec Dt:

01/19/2024

4

VALNEVA SWEDEN AB

Exec Dt:

01/19/2024

Assignee

1

WILMINGTON TRUST, NATIONAL ASSOCIATION

50 SOUTH SIXTH STREET, SUITE 1290

MINNEAPOLIS, MINNESOTA 55402

Correspondence name and address
	COVINGTON & BURLING LLP
	ONE CITY CENTER, 850 TENTH ST NW
	ATTN: PATENT DOCKET
	WASHINGTON, DC 20001

Search Results as of: 06/14/2024 08:00 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6

| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT